glp 1 3 months GLP-1/GIP Results After 1, 3, and 6 3 Months Transformation Weight Loss
Description
Retatrutide Triple Agonist (GLP-1/GIP/GCG) for advanced metabolic research
Roche reported positive Phase II topline data showing that its once-weekly dual glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonist CT-388 achieved substantial, sustained, and dose-dependent weight loss through 48 weeks
Also, the drug needs to be taken on an empty stomach immediately on waking, with no more than 120 mL of water
16, 2025 Weight-loss drugs like Ozempic and Zepbound appear to reduce alcohol cravings, but doctors have been at a loss to explain why until now.
